Monophasic Disease Course in Systemic Lupus Erythematosus.

CONCLUSION: A monophasic disease course was observed in 7.5% in this inception cohort. Patients sustained remission for 18 years on average, eventually without medications. Further study of such patients may provide unique pathophysiologic insights for SLE. PMID: 29858240 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29858240?dopt=Abstract

Source: J Rheumatol - June 1, 2018 Category: Rheumatology Authors: Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB Tags: J Rheumatol Source Type: research